These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 10216689)

  • 1. Drug watch.
    Indian Pediatr; 1998 Jul; 35(7):696. PubMed ID: 10216689
    [No Abstract]   [Full Text] [Related]  

  • 2. Challenges in the management of visceral leishmaniasis.
    Sundar S; Kumar A
    Indian Pediatr; 2005 Jun; 42(6):523-6. PubMed ID: 15995268
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of aminosidine (paromomycin) and sodium stibogluconate for treatment of canine leishmaniasis.
    Poli A; Sozzi S; Guidi G; Bandinelli P; Mancianti F
    Vet Parasitol; 1997 Aug; 71(4):263-71. PubMed ID: 9299695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in the treatment of visceral leishmaniasis.
    Davidson RN; Croft SL
    Trans R Soc Trop Med Hyg; 1993; 87(2):130-1, 141. PubMed ID: 8393221
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug combinations for visceral leishmaniasis.
    Olliaro PL
    Curr Opin Infect Dis; 2010 Dec; 23(6):595-602. PubMed ID: 20871400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutaneous leishmaniasis.
    Bailey MS; Lockwood DN
    Clin Dermatol; 2007; 25(2):203-11. PubMed ID: 17350500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sodium stibogluconate.
    Shrestha NK
    Clin Infect Dis; 2006 Nov; 43(10):1371-2. PubMed ID: 17051510
    [No Abstract]   [Full Text] [Related]  

  • 8. Amphotericin B in visceral leishmaniasis.
    Jha BB
    Indian Pediatr; 1996 Nov; 33(11):971. PubMed ID: 9141838
    [No Abstract]   [Full Text] [Related]  

  • 9. [A case of antimony resistant kala-azar cured with amphotericin B].
    Chen SB; Yang CM; Zhang CJ
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2007 Jun; 25(3):inside front page. PubMed ID: 18038767
    [No Abstract]   [Full Text] [Related]  

  • 10. Post-kala-azar dermal leishmaniasis with visceral leishmaniasis: a rare presentation.
    Rijal A; Agrawal S; Agarwalla A; Agrawal A; Rijal S
    Int J Dermatol; 2005 Jun; 44(6):494-6. PubMed ID: 15941439
    [No Abstract]   [Full Text] [Related]  

  • 11. Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic.
    Sundar S; More DK; Singh MK; Singh VP; Sharma S; Makharia A; Kumar PC; Murray HW
    Clin Infect Dis; 2000 Oct; 31(4):1104-7. PubMed ID: 11049798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical aspects of paediatric visceral leishmaniasis in North-west Ethiopia.
    Diro E; Lynen L; Gebregziabiher B; Assefa A; Lakew W; Belew Z; Hailu A; Boelaert M; van Griensven J
    Trop Med Int Health; 2015 Jan; 20(1):8-16. PubMed ID: 25329449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A difficult diagnosis?].
    Kager PA
    Ned Tijdschr Geneeskd; 1985 Jun; 129(26):1217-20. PubMed ID: 2991785
    [No Abstract]   [Full Text] [Related]  

  • 14. Visceral leishmaniasis: a rare cause of post-transplant fever and pancytopenia.
    Rajaram KG; Sud K; Kohli HS; Gupta KL; Sakhuja V
    J Assoc Physicians India; 2002 Jul; 50():979-80. PubMed ID: 12126362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of serum amylase, lipase and associated factors among patients with visceral leishmaniasis treated with sodium stibogluconate/paromomycin at University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia.
    Mengstie TA; Endale HT; Mulaw T; Abdella AM; Mohammed R; Malik T; Dessie G
    PLoS One; 2021; 16(10):e0257229. PubMed ID: 34597312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffuse cutaneous dissemination of visceral leishmaniasis during human immunodeficiency virus (HIV) infection, despite negligible immunodeficiency: repeated failure of liposomal amphotericin B administration, followed by successful long-term pentamidine and paromomycin administration.
    Manfredi R; Marinacci G; Calza L; Passarini B
    Int J Antimicrob Agents; 2008 Jun; 31(6):590-2. PubMed ID: 18456464
    [No Abstract]   [Full Text] [Related]  

  • 17. Sodium stibogluconate-sensitive visceral leishmaniasis in the non-endemic hilly region of Uttarakhand, India.
    Verma SK; Ahmad S; Shirazi N; Kusum A; Kaushik RM; Barthwal SP
    Trans R Soc Trop Med Hyg; 2007 Jul; 101(7):730-2. PubMed ID: 17382981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Poor patients do not make a market].
    Holen Ø
    Tidsskr Nor Laegeforen; 2004 Dec; 124(24):3226-8. PubMed ID: 15608773
    [No Abstract]   [Full Text] [Related]  

  • 19. Visceral leishmaniasis presenting as generalized lymphadenopathy in Nepal.
    Sah SP; Raj GA; Kalra OP; Ansari JA
    Southeast Asian J Trop Med Public Health; 1999 Mar; 30(1):36-7. PubMed ID: 10695785
    [No Abstract]   [Full Text] [Related]  

  • 20. Paromomycin.
    Davidson RN; den Boer M; Ritmeijer K
    Trans R Soc Trop Med Hyg; 2009 Jul; 103(7):653-60. PubMed ID: 18947845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.